MyFinsight
Home
Blog
About
Back
Cash Flow
Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. (SMNR)
source: myfinsight.com
Proceeds from related
party loans
$2,734K
Net cash provided by
financing activities
$2,074K
Canceled cashflow
$660K
Net change in cash
and cash...
-$64K
Canceled cashflow
$2,074K
Stock-based compensation
$1,295K
Accounts payable
$495K
Accrued expenses
$334K
Interest accrued on
promissory notes
$123K
Prepaid expenses
-$13K
Repayment of promissory
notes
$660K
Net cash used in
operating activities
-$2,138K
Canceled cashflow
$2,260K
Net loss
-$4,347K
Other assets
$51K
Back